Publication | Open Access

Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12

Anti-tumor Immunity SpecificTumor ImmunologyCancer ImmunosurveillanceGliomaImmunologyTumor ImmunityTherapeutic VaccineImmunomodulationImmunotherapyMedicineCell BiologyTumor Microenvironment